UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055874 |
|---|---|
| Receipt number | R000063626 |
| Scientific Title | Survey on cognitive function scales for major depressive disorder in Japan |
| Date of disclosure of the study information | 2024/11/01 |
| Last modified on | 2025/04/21 14:11:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Survey on cognitive function scales for major depressive disorder in Japan
Acronym
Survey on cognitive function scales for major depressive disorder in Japan
Scientific Title
Survey on cognitive function scales for major depressive disorder in Japan
Scientific Title:Acronym
Survey on cognitive function scales for major depressive disorder in Japan
Region
| Japan |
Condition
Condition
Major depressive disorder (MDD)
Classification by specialty
| Psychosomatic Internal Medicine | Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In psychiatrists who possess sufficient knowledge about the scales and use them in their research; How do they perceive the characteristics of each cognitive function scale?; What cognitive function scales are used to evaluate cognitive function?
Basic objectives2
Others
Basic objectives -Others
Web-based questionnaire
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
Identify the characteristics of each targeted cognitive function scale.
Participant will rate the following perspectives on a scale of 1-5. (difficulty of introducing a new routine clinical practice / knowledge and experience required for accurate evaluation / time required from explanation to completion / difficulty of result calculation / knowledge and experience required for effective utilization of results)
Key secondary outcomes
Estimate the usage rate of each cognitive function scale.
Participants will answer whether they had experience using each rating scale.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Experience with at least one of the cognitive function scales targeted in this study.
Psychiatrists.
Key exclusion criteria
None
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Miwa |
| Middle name | |
| Last name | Izutsu |
Organization
Takeda Pharmaceutical Company Limited.
Division name
Japan Medical Office
Zip code
103-8668
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan
TEL
03-3242-1256
miwa.izutsu@takeda.com
Public contact
Name of contact person
| 1st name | Fumie |
| Middle name | |
| Last name | Tokuda |
Organization
Takeda Pharmaceutical Company Limited.
Division name
Japan Medical Office
Zip code
103-8668
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan
TEL
03-3242-1256
Homepage URL
fumie.tokuda@takeda.com
Sponsor or person
Institute
Takeda Pharmaceutical Company Limited.
Institute
Department
Personal name
Funding Source
Organization
Takeda Pharmaceutical Company Limited.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Takahashi Clinic Ethics Committee
Address
Medicalhat 1F , 5-1-31 ,kitamachi ,iwaya, nada-ku, kobe-shi, Hyogo
Tel
078-882-6432
kishimoto.satoshi@neues.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 08 | Month | 22 | Day |
Date of IRB
| 2024 | Year | 10 | Month | 15 | Day |
Anticipated trial start date
| 2024 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 11 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2025 | Year | 03 | Month | 12 | Day |
Other
Other related information
None
Management information
Registered date
| 2024 | Year | 10 | Month | 18 | Day |
Last modified on
| 2025 | Year | 04 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063626
